Authors:
Sitnitskaya, Y
Rochford, G
Rigaud, M
Essajee, S
Pollack, H
Krasinski, K
Borkowsky, W
Citation: Y. Sitnitskaya et al., Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995-1999, CLIN INF D, 33(1), 2001, pp. E3-E7
Authors:
Cunningham, CK
Wara, DW
Kang, MH
Fenton, T
Hawkins, E
McNamara, J
Mofenson, L
Duliege, AM
Francis, D
McFarland, EJ
Borkowsky, W
Citation: Ck. Cunningham et al., Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women, CLIN INF D, 32(5), 2001, pp. 801-807
Authors:
Bush, L
Malecki, J
Wiersma, S
Cahill, K
Fried, R
Grossman, M
Borkowsky, W
Citation: L. Bush et al., Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001 (Reprinted from MMWR, vol 50, pg 889, 2001), J AM MED A, 286(17), 2001, pp. 2086-2088
Authors:
McFarland, EJ
Borkowsky, W
Fenton, T
Wara, D
McNamara, J
Samson, P
Kang, MH
Mofenson, L
Cunningham, C
Duliege, AM
Sinangil, F
Spector, SA
Jimenez, E
Bryson, Y
Burchett, S
Frenkel, LM
Yogev, R
Gigliotti, F
Luzuriaga, K
Livingston, RA
Citation: Ej. Mcfarland et al., Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine, J INFEC DIS, 184(10), 2001, pp. 1331-1335
Authors:
Essajee, SM
Pollack, H
Rochford, G
Oransky, I
Krasinski, K
Borkowsky, W
Citation: Sm. Essajee et al., Early changes in quasispecies repertoire in HIV-infected infants: Correlation with disease progression, AIDS RES H, 16(18), 2000, pp. 1949-1957
Authors:
Nachman, SA
Stanley, K
Yogev, R
Pelton, S
Wiznia, A
Lee, S
Mofenson, L
Fiscus, S
Rathore, M
Jimenez, E
Borkowsky, W
Pitt, J
Smith, ME
Wells, B
McIntosh, K
Citation: Sa. Nachman et al., Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children - A randomized controlled trial, J AM MED A, 283(4), 2000, pp. 492-498
Authors:
Spiegel, HML
Ogg, GS
DeFalcon, E
Sheehy, ME
Monard, S
Haslett, PAJ
Gillespie, G
Donahoe, SM
Pollack, H
Borkowsky, W
McMichael, AJ
Nixon, DF
Citation: Hml. Spiegel et al., Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells, J VIROLOGY, 74(2), 2000, pp. 1018-1022
Authors:
Frenkel, LM
Capparelli, EV
Dankner, WM
Xu, J
Smith, IL
Ballow, A
Culnane, M
Read, JS
Thompson, M
Mohan, KM
Shaver, A
Robinson, CA
Stempien, MJ
Burchett, SK
Melvin, AJ
Borkowsky, W
Petru, A
Kovacs, A
Yogev, R
Goldsmith, J
McFarland, EJ
Spector, SA
Citation: Lm. Frenkel et al., Oral ganciclovir in children: Pharmacokinetics, safety, tolerance, and antiviral effects, J INFEC DIS, 182(6), 2000, pp. 1616-1624
Authors:
Spiegel, HML
Chandwani, R
Sheehy, ME
Dobroszycki, J
Fennelly, G
Wiznia, A
Radding, J
Rigaud, M
Pollack, H
Borkowsky, W
Rosenberg, M
Nixon, DF
Citation: Hml. Spiegel et al., The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children, J INFEC DIS, 182(1), 2000, pp. 88-95
Authors:
Borkowsky, W
Stanley, K
Douglas, SD
Lee, S
Wiznia, A
Pelton, S
Yogev, R
McIntosh, K
Nachman, S
Citation: W. Borkowsky et al., Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children, J INFEC DIS, 182(1), 2000, pp. 96-103
Authors:
King, JC
Borkowsky, W
Mahidhara, N
Madore, D
Shapiro, ED
Rutstein, RM
Tan, TQ
Farley, JJ
Dankner, WM
Nachman, S
Simoes, E
Flynn, PM
Clemens, J
Hamilton, RG
Citation: Jc. King et al., Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus, J INFEC DIS, 181(5), 2000, pp. 1817-1821
Authors:
Borkowsky, W
Wara, D
Fenton, T
McNamara, J
Kang, MH
Mofenson, L
McFarland, E
Cunningham, C
Duliege, AM
Francis, D
Bryson, Y
Burchett, S
Spector, SA
Frenkel, LM
Starr, S
Van Dyke, R
Jimenez, E
Citation: W. Borkowsky et al., Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines, J INFEC DIS, 181(3), 2000, pp. 890-896
Authors:
Essajee, SM
Kim, M
Gonzalez, C
Rigaud, M
Kaul, A
Chandwani, S
Hoover, W
Lawrence, R
Spiegel, H
Pollack, H
Krasinski, K
Borkowsky, W
Citation: Sm. Essajee et al., Immunologic and virologic responses to HAART in severely immunocompromisedHIV-1-infected children, AIDS, 13(18), 1999, pp. 2523-2532
Authors:
Kostrikis, LG
Neumann, AU
Thomson, B
Korber, BT
McHardy, P
Karanicolas, R
Deutsch, L
Huang, YX
Lew, JF
McIntosh, K
Pollack, H
Borkowsky, W
Spiegel, HML
Palumbo, P
Oleske, J
Bardeguez, A
Luzuriaga, K
Sullivan, J
Wolinsky, SM
Koup, RA
Ho, DD
Moore, JP
Citation: Lg. Kostrikis et al., A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants, J VIROLOGY, 73(12), 1999, pp. 10264-10271
Authors:
Luzuriaga, K
Wu, HL
McManus, M
Britto, P
Borkowsky, W
Burchett, S
Smith, B
Mofenson, L
Sullivan, JL
Citation: K. Luzuriaga et al., Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants, J VIROLOGY, 73(1), 1999, pp. 362-367
Authors:
Spiegel, HML
DeFalcon, E
Ogg, GS
Larsson, M
Beadle, TJ
Tao, P
McMichael, AJ
Bhardwaj, N
O'Callaghan, C
Cox, WI
Krasinski, K
Pollack, H
Borkowsky, W
Nixon, DE
Citation: Hml. Spiegel et al., Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children, J INFEC DIS, 180(2), 1999, pp. 359-368
Authors:
Zhang, LQ
Lewin, SR
Markowitz, M
Lin, HH
Skulsky, E
Karanicolas, R
He, YX
Jin, X
Tuttleton, S
Vesanen, M
Spiegel, H
Kost, R
van Lunzen, J
Stellbrink, HJ
Wolinsky, S
Borkowsky, W
Palumbo, P
Kostrikis, LG
Ho, DD
Citation: Lq. Zhang et al., Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy, J EXP MED, 190(5), 1999, pp. 725-732
Authors:
Lambert, JS
McNamara, J
Katz, SL
Fenton, T
Kang, MH
VanCott, TC
Livingston, R
Hawkins, E
Moye, J
Borkowsky, W
Johnson, D
Yogev, S
Duliege, AM
Francis, L
Gershon, A
Wara, D
Martin, N
Levin, F
McSherry, F
Smith, G
Citation: Js. Lambert et al., Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children, J ACQ IMM D, 19(5), 1998, pp. 451-461